Daiichi Sankyo
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.
CEOHiroyuki Okuzawa
CEOHiroyuki Okuzawa
Employees20,171
Employees20,171
HeadquartersTokyo, Tokyo
HeadquartersTokyo, Tokyo
Founded2005
Founded2005
Employees20,171
Employees20,171
DSNKY Key Statistics
Market cap33.27B
Market cap33.27B
Price-Earnings ratio16.78
Price-Earnings ratio16.78
Dividend yield1.39%
Dividend yield1.39%
Average volume374.72K
Average volume374.72K
High today$18.24
High today$18.24
Low today$17.27
Low today$17.27
Open price$18.24
Open price$18.24
Volume9.09K
Volume9.09K
52 Week high$24.77
52 Week high$24.77
52 Week low$14.98
52 Week low$14.98
DSNKY News
TipRanks 3d
Daiichi Sankyo Updates Long-Term TURALIO Liver-Safety StudyDaiichi Sankyo Company (DSKYF) announced an update on their ongoing clinical study. Study Overview: Daiichi Sankyo’s study, officially titled “A Long-term Stud...
Investing.com 7d
Daiichi Sankyo Q2 FY2026 slides: oncology surge drives record growth - Investing.com...
Analyst ratings
76%
of 17 ratingsBuy
76.5%
Hold
23.5%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.